Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
NCRI logo

In 2014 the National Cancer Research Institute (NCRI) moved to a new model of joint working among cancer CTUs. In place of accreditation, an NCRI Cancer CTU Group was established to bring together the field leaders that contribute at a national level to the advancement of cancer clinical trials, using simpler entry criteria that complement UKCRC registration.

OCTRU applied to become an NCRI Cancer Clinical Trial Unit and we are pleased to announce that we were successful. Please click this link to find out who all 16 units are http://www.ncri.org.uk/wp-content/uploads/2014/10/NCRI-Cancer-CTU-Group-Members-2014.pdf

Similar stories

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.